677 related articles for article (PubMed ID: 19142100)
1. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
2. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
3. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
4. High free thyroxine levels are associated with QTc prolongation in males.
van Noord C; van der Deure WM; Sturkenboom MC; Straus SM; Hofman A; Visser TJ; Kors JA; Witteman JC; Stricker BH
J Endocrinol; 2008 Jul; 198(1):253-60. PubMed ID: 18463146
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
6. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
[TBL] [Abstract][Full Text] [Related]
8. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
Corović N; Duraković Z; Misigoj-Duraković M
Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
[TBL] [Abstract][Full Text] [Related]
10. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
Straus SM; Kors JA; De Bruin ML; van der Hooft CS; Hofman A; Heeringa J; Deckers JW; Kingma JH; Sturkenboom MC; Stricker BH; Witteman JC
J Am Coll Cardiol; 2006 Jan; 47(2):362-7. PubMed ID: 16412861
[TBL] [Abstract][Full Text] [Related]
11. Assessing Prolongation of the Heart Rate Corrected QT Interval in Users of Tricyclic Antidepressants: Advice to Use Fridericia Rather Than Bazett's Correction.
Noordam R; van den Berg ME; Niemeijer MN; Aarts N; Leening MJ; Deckers JW; Hofman A; Rijnbeek PR; Eijgelsheim M; Kors JA; Stricker BH; Visser LE
J Clin Psychopharmacol; 2015 Jun; 35(3):260-5. PubMed ID: 25856783
[TBL] [Abstract][Full Text] [Related]
12. Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children.
Kuppermann N; Park J; Glatter K; Marcin JP; Glaser NS
Arch Pediatr Adolesc Med; 2008 Jun; 162(6):544-9. PubMed ID: 18524745
[TBL] [Abstract][Full Text] [Related]
13. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
14. Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval.
Funai Y; Funao T; Ikenaga K; Takahashi R; Hase I; Nishikawa K
Osaka City Med J; 2014 Jun; 60(1):11-9. PubMed ID: 25272563
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of QT interval in patients treated with psychotropic drugs.
Novotny T; Florianova A; Ceskova E; Weislamplova M; Palensky V; Tomanova J; Sisakova M; Toman O; Spinar J
Int J Cardiol; 2007 May; 117(3):329-32. PubMed ID: 16863665
[TBL] [Abstract][Full Text] [Related]
16. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.
Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P
J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
[TBL] [Abstract][Full Text] [Related]
18. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
[TBL] [Abstract][Full Text] [Related]
19. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
20. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
